Soluble Urokinase-Type Plasminogen Activator Receptor in Black Americans with CKD.

Shengyuan LuoJosef CoreshAdrienne TinCasey M RebholzTeresa K ChenSalim Salim HayekMelissa TracyMichael S LipkowitzLawrence J AppelAndrew S LeveyLesley A InkerJochen ReiserMorgan Erika Grams

Published in: Clinical journal of the American Society of Nephrology : CJASN (2018)

Higher suPAR was associated with various adverse outcomes in Black Americans with CKD, with and without APOL1 kidney disease risk variants, independently of proteinuria and GFR.

Keyphrases

chronic kidney disease
copy number
gene expression